About Brihans Laboratories Private Limited
Data last updated:
Brihans Laboratories Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the animal pharmaceuticals and healthcare segment of the pharmaceuticals sector. It was incorporated on 29 April 2009 and has been in existence for over 17 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24100MH2009PTC304954. Its GSTIN is 27AADCB7839A1ZT (Maharashtra). The company holds 3 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹4 Cr and a paid-up capital of ₹2.53 Cr. It is led by directors Udai Kothari and Deepak Kothari.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2024, the company reported a revenue of ₹31.05 Cr, a decline of 8% compared to the previous year. For the same year it recorded a net loss of ₹3.66 Cr (net margin -11.8%) and EBITDA of ₹36.7 Lakh (EBITDA margin 1.2%). Revenue has declined at a compounded annual rate (CAGR) of 1% over three years and 8% over five years.
The company has about 127 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Brihans Laboratories. As per MCA filings, the company has satisfied charges of ₹10.77 Lakh on record. Court records list 6 cases involving the company, including 5 filed by the company and 1 filed against it; 1 case is pending. The company has 2 deals on record (2 funding rounds), with disclosed funding of ₹2.52 Cr; the latest was in February 2017. Its 4 peer companies in the Pharma industry (Animal Pharma), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger and 1 smaller; the largest is Stanex Drugs and Chemicals Private Limited with revenue of ₹36.54 Cr.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website brihans.in.
Company details
CIN history
Brihans Laboratories has one previous CIN (Corporate Identification Number): U24100PN2009PTC133866. The current CIN is U24100MH2009PTC304954, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24100MH2009PTC304954 | Current |
| U24100PN2009PTC133866 | Previous |
Contact details
Brihans Laboratories Private Limited's registered office is in Mumbai, Maharashtra. Its website is brihans.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressVaman Techno Centre 7th Floor Makwana Road Off Andheri – Kurla Road Marol Naka Andh, Eri (East), Mumbai, Maharashtra, India – 400059
- IndustryPharma, Animal Pharmaceuticals & Healthcare
To see the full contact details of Brihans Laboratories Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Brihans Laboratories operates one associated brand: Brihans Laboratories. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Laboratory services, marketing, and operations in India. | brihans.in |
Business activity
The main business activity of Brihans Laboratories is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Brihans Laboratories Private Limited, buy the company report.
Financials of Brihans Laboratories Private Limited
FY 2025 filings availableBrihans Laboratories Private Limited reported revenue of ₹31.05 Cr (down 8% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 8% over five years, including a 8% fall in the latest year. EBITDA rose 97% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹36.7 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹3.66 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.2% | ||||
| Net Profit Margin | -11.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Brihans Laboratories Private Limited, buy the company report.
Board of directors of Brihans Laboratories Private Limited
Brihans Laboratories has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Udai Kothari Also directs: U. Y. Fincorp Limited, Brima Sagar Maharashtra Distilleries Limited, Usha Colonisers Limited and 5 more | Director | 29 Apr 2009 | 17 Years 5 Months | Current |
| Deepak Kothari | Director | 29 Apr 2009 | 17 Years 5 Months | Current |
Peer comparison
Brihans Laboratories Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Animal Pharma), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Stanex Drugs and Chemicals Private Limited | ₹36.54 Cr (FY 2024) | -47.0% | Hyderabad, Telangana, India | |||
| Vetrina Healthcare Private Limited | ₹35.8 Cr (FY 2024) | 61.0% | Pune, Maharashtra, India | |||
| Vetindia Pharmaceuticals Limited | ₹35.78 Cr (FY 2024) | -10.0% | Telangana, India | |||
| Brihans Laboratories Private Limitedthis company | ₹31.05 Cr (FY 2024) | -₹3.66 Cr | -11.8% | -8.0% | 127 | Mumbai, Maharashtra, India |
| Prashanti Formulations Limited | ₹29.89 Cr (FY 2025) | -26.0% | Hoshiarpur, Punjab, India |
To see the full peer comparison of Brihans Laboratories Private Limited, buy the company report.
Auditor
Brihans Laboratories Private Limited is audited by SAHAJWANI NARANG & ASSOCIATES for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SAHAJWANI NARANG & ASSOCIATES | FY 2021 | 130142W |
Shareholding
The shareholding of Brihans Laboratories Private Limited is on record for 5 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Brihans Laboratories Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 03 May 2018 | 100223145 | Others | ₹10.77 Lakh | Satisfied |
To see the full charge records of Brihans Laboratories Private Limited, buy the company report.
Total charge records: 1 View all charges
Deals & funding
Brihans Laboratories Private Limited has 2 deals on record (2 funding rounds), with disclosed funding of ₹2.52 Cr; the latest was in February 2017.
Deals on record (2 of 2)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Feb 2017 | Funding round | ₹2.5 Cr | Investors: U. Y. Fincorp Limited , 2 individuals |
| Jan 2011 | Funding round | ₹2.3 Lakh | Investors: 2 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Brihans Laboratories Private Limited has 6 court cases on record: 5 filed by Brihans Laboratories, 1 filed against it. 1 case is pending and 5 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 4 | 0 | 0 |
| District courts | 2 | 1 | 1 |
Cases on record (5 of 6)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Pune, Maharashtra | Civil suit | Filed by the company against Rathi Feeds India Pvt. Ltd. and 4 others | Disposed |
| High Court of Delhi | Court case (C.O. (COMM.IPD-TM)) | Filed by the company against Avaenta Pharmaceuticals Pvt Ltd. and Anr. | Disposed |
| District court, Patna, Bihar | Court case (Cr. Case Complaint (P)) | Filed against the company by an individual | Pending |
| High Court | Court case (CARAP) | Filed by the company against Kunal Krishna Rastogi Proprietor of Ms Solomon and Co WS Agencies | Disposed |
| High Court | Arbitration matter | Filed by the company against Ela Praveen Proprietress of Pratham Enterprises | Disposed |
To see the full case history of Brihans Laboratories Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Brihans Laboratories Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Brihans Laboratories Private Limited has a workforce of 127 employees on its EPFO records as of Mar 30, 2024, across 1 active EPFO establishment.
GST
Brihans Laboratories has 3 GST registrations: 2 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AADCB7839A1ZT | Maharashtra | Active | 01 Jul 2017 |
| 19AADCB7839A1ZQ | West Bengal | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Brihans Laboratories Private Limited, buy the company report.
Recent activity
Brihans Laboratories Private Limited has 4 board changes on record since 2009: 2 appointments and 2 cessations. The latest: Dipti Kothari ceased to be Director on 31 Jul 2017.
Frequently asked questions
Brihans Laboratories is an active private limited company based in Mumbai, Maharashtra, India. The company works in animal pharmaceuticals and healthcare, within the pharma industry. It was incorporated on 29 April 2009 (17+ years old) and is registered under CIN U24100MH2009PTC304954.
Brihans Laboratories has 2 current directors:
- Udai Kothari - Director
- Deepak Kothari - Director
The latest financial statements of Brihans Laboratories on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Brihans Laboratories is 27AADCB7839A1ZT, registered in Maharashtra. The company has 3 GST registrations in all, of which 2 are active and 1 is cancelled or inactive. Other active GSTINs include 19AADCB7839A1ZQ (West Bengal).
The CIN (Corporate Identification Number) of Brihans Laboratories is U24100MH2009PTC304954. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Brihans Laboratories has 6 court cases on record: 5 filed by the company and 1 filed against it. 1 is pending. Most are in the high courts.
Brihans Laboratories was incorporated on 29 April 2009, making it 17+ years old. It is registered with the Registrar of Companies, Mumbai.
Brihans Laboratories has 2 deals on record (2 funding rounds), with disclosed funding of ₹2.52 Cr; the latest was in February 2017.
The peers of Brihans Laboratories by revenue are Stanex Drugs and Chemicals Private Limited, Vetrina Healthcare Private Limited, Vetindia Pharmaceuticals Limited, Prashanti Formulations Limited, all in the Pharma industry (Animal Pharma), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Dipti Kothari ceased to be Director on 31 Jul 2017. Rameshchandra Prabhakar Barve ceased to be Director on 01 Aug 2009. Deepak Kothari was appointed as Director on 29 Apr 2009. Brihans Laboratories has 4 board changes on record in total.
Brihans Laboratories can be reached through the website brihans.in. Its registered office is in Mumbai, Maharashtra, India.